Overall Status

Completed (168)

Unknown status (59)

Recruiting (48)

Not yet recruiting (29)

Terminated (23)

Active, not recruiting (12)

Withdrawn (12)

Enrolling by invitation (1)

Phase

n/a (152)

phase 2 (34)

phase 4 (28)

phase 3 (25)

phase 1 (16)

early phase 1 (4)

phase 1/phase 2 (4)

phase 2/phase 3 (3)

Study Documents

Clinical Study Report (1)

Intervention Type

drug (124)

procedure (90)

other (63)

device (43)

diagnostic test (25)

behavioral (6)

biological (6)

radiation (3)

dietary supplement (2)

Funder Type

Other (299)

Industry (40)

NIH (12)

U.S. Fed (1)

Study Type

Interventional (266)

Observational (86)

Tubal flushing

Showing 351 - 352 of 352

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

HDL Cholesterol, Coronary Arteriosclerosis, Lipoproteins Trial in Craigavon (Nicotinic acid)

Unknown status

HDL Cholesterol
+2 more

Nicotinic acid

Craigavon, United Kingdom

Craigavon Cardiac Centre

Sep 11, 2006

Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia

Completed

Schizophrenia
Cannabis Abuse

Jena, Thueringen, Germany

University of Jena, Department of Psychiatry

Oct 11, 2006